STOCK TITAN
  1. Home
  2. Sec-filings
  3. JAGX
  4. [EFFECT] Jaguar Health, Inc. SEC Filing

[EFFECT] Jaguar Health, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 27, 2025 4:00 P.M.
Form: S-3
CIK: 0001585608
Company Name: Jaguar Health, Inc.
File Number: 333-288202

Source: View Original Filing on SEC EDGAR

Stock JAGX logo
Jaguar Health Inc

NASDAQ:JAGX

JAGX Rankings

#6796 Ranked by Market Cap
N/A Ranked by Dividends

JAGX Latest News

Jan 22, 2026
Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
Jan 14, 2026
Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts
Jan 12, 2026
Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million
Jan 6, 2026
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
Jan 2, 2026
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

JAGX Latest SEC Filings

Jan 23, 2026
[8-K] Jaguar Health, Inc. Reports Material Event
Jan 21, 2026
[Form 4] Jaguar Health, Inc. Insider Trading Activity
Jan 21, 2026
[Form 4] Jaguar Health, Inc. Insider Trading Activity
Jan 21, 2026
[Form 4] Jaguar Health, Inc. Insider Trading Activity
Jan 12, 2026
[8-K] Jaguar Health, Inc. Reports Material Event

JAGX Stock Data

3.19M
2.19M
34.76%
0.63%
3.04%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO